Evolution of Treatment Tactics for Patients with Trunk Lesions of Coronary Arteries

O. Levchyshyna, E. V. Aksyonov, S. V. Salo
{"title":"Evolution of Treatment Tactics for Patients with Trunk Lesions of Coronary Arteries","authors":"O. Levchyshyna, E. V. Aksyonov, S. V. Salo","doi":"10.26693/jmbs07.06.023","DOIUrl":null,"url":null,"abstract":"Damage to the trunk of the left coronary artery is the most dangerous manifestation of coronary atherosclerosis. Mortality with this type of lesions occurs by 3–4 times more often compared to lesions of other segments of coronary arteries. On the basis of previous clinical studies demonstrating advantages of coronary artery bypass grafting over drug therapy in terms of patient survival, coronary artery bypass grafting has long been considered the gold standard for the treatment of these lesions. The purpose of the work was to study the literature data on the evolution and peculiarities of the choice of methods of surgical treatment of coronary heart disease in patients with severe lesions of the trunk of the left coronary artery. Results and discussion. Along with the improvement of endovascular instrumentation, stenting procedures, antithrombotic agents, as well as concomitant drug therapy, percutaneous coronary interventions for lesions of the left trunk are becoming more and more widespread and show favorable clinical results in these patients. This is evidenced by the data of many randomized multicenter studies (SYNTAX, EXCEL). Based on the results of these studies, ESC/EACTS approved the following guidelines for myocardial revascularization in 2018. Percutaneous coronary interventions are indicated in the case of damage to the left trunk with scores on the SYNTAX scale less than 22 – class I, scores on the SYNTAX scale 23–32 – class IIa, and scores on the SYNTAX scale greater than 32 – class III. However, it is worth noting that both the American and the European guidelines recommend a discussion by a team of endovascular surgeons, cardiologists and cardiac surgeons (Heart Team) when choosing a treatment strategy for coronary artery disease patients with lesions of the trunk of the left coronary artery. Since the data of many studies on the treatment of patients with lesions of the trunk of the left coronary artery remain quite contradictory and ambiguous. Conclusion. Current literature data have shown that left coronary artery stenting is a fairly safe procedure, with a high rate of immediate success, low mortality, and few complications, especially in low-risk surgical patients. The use of stents with medical coating made it possible to reduce the frequency of repeated interventions to 10–12%. A number of issues remain, the solution of which would allow optimizing the application of this technique. These include: development of indications for surgical or endovascular treatment of lesions of the left coronary artery trunk, optimization of stenting techniques, assessment of the significance of concomitant pathology in the effectiveness of treatment of patients with lesions of the left coronary artery trunk","PeriodicalId":413454,"journal":{"name":"Ukraïnsʹkij žurnal medicini, bìologìï ta sportu","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ukraïnsʹkij žurnal medicini, bìologìï ta sportu","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26693/jmbs07.06.023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Damage to the trunk of the left coronary artery is the most dangerous manifestation of coronary atherosclerosis. Mortality with this type of lesions occurs by 3–4 times more often compared to lesions of other segments of coronary arteries. On the basis of previous clinical studies demonstrating advantages of coronary artery bypass grafting over drug therapy in terms of patient survival, coronary artery bypass grafting has long been considered the gold standard for the treatment of these lesions. The purpose of the work was to study the literature data on the evolution and peculiarities of the choice of methods of surgical treatment of coronary heart disease in patients with severe lesions of the trunk of the left coronary artery. Results and discussion. Along with the improvement of endovascular instrumentation, stenting procedures, antithrombotic agents, as well as concomitant drug therapy, percutaneous coronary interventions for lesions of the left trunk are becoming more and more widespread and show favorable clinical results in these patients. This is evidenced by the data of many randomized multicenter studies (SYNTAX, EXCEL). Based on the results of these studies, ESC/EACTS approved the following guidelines for myocardial revascularization in 2018. Percutaneous coronary interventions are indicated in the case of damage to the left trunk with scores on the SYNTAX scale less than 22 – class I, scores on the SYNTAX scale 23–32 – class IIa, and scores on the SYNTAX scale greater than 32 – class III. However, it is worth noting that both the American and the European guidelines recommend a discussion by a team of endovascular surgeons, cardiologists and cardiac surgeons (Heart Team) when choosing a treatment strategy for coronary artery disease patients with lesions of the trunk of the left coronary artery. Since the data of many studies on the treatment of patients with lesions of the trunk of the left coronary artery remain quite contradictory and ambiguous. Conclusion. Current literature data have shown that left coronary artery stenting is a fairly safe procedure, with a high rate of immediate success, low mortality, and few complications, especially in low-risk surgical patients. The use of stents with medical coating made it possible to reduce the frequency of repeated interventions to 10–12%. A number of issues remain, the solution of which would allow optimizing the application of this technique. These include: development of indications for surgical or endovascular treatment of lesions of the left coronary artery trunk, optimization of stenting techniques, assessment of the significance of concomitant pathology in the effectiveness of treatment of patients with lesions of the left coronary artery trunk
冠状动脉主干病变治疗策略的演变
左冠状动脉干损伤是冠状动脉粥样硬化最危险的表现。与冠状动脉其他部分的病变相比,这种类型病变的死亡率高出3-4倍。基于先前的临床研究表明冠状动脉旁路移植术在患者生存方面优于药物治疗,冠状动脉旁路移植术一直被认为是治疗这些病变的金标准。本研究的目的是研究左冠状动脉干严重病变患者冠心病手术治疗方法选择的演变和特点的文献资料。结果和讨论。随着血管内器械、支架置入技术、抗栓药物以及伴随药物治疗的改进,经皮冠状动脉介入治疗左主干病变的应用越来越广泛,在这些患者中取得了良好的临床效果。许多随机多中心研究的数据证明了这一点(SYNTAX, EXCEL)。基于这些研究的结果,ESC/EACTS于2018年批准了以下心肌血运重建指南。当左躯干损伤时,SYNTAX评分小于22分(I类),SYNTAX评分为23-32分(IIa类),SYNTAX评分大于32分(III类),则需要经皮冠状动脉介入治疗。然而,值得注意的是,美国和欧洲的指南都建议在选择左冠状动脉干病变的冠状动脉疾病患者的治疗策略时,由血管内外科医生、心脏病专家和心脏外科医生(Heart team)组成的团队进行讨论。由于许多关于左冠状动脉干病变患者治疗的研究数据仍然非常矛盾和模糊。结论。目前的文献资料表明,左冠状动脉支架置入术是一种相当安全的手术,其即时成功率高,死亡率低,并发症少,特别是在低风险手术患者中。使用带有医用涂层的支架可以将重复干预的频率降低到10-12%。仍然存在一些问题,这些问题的解决方案将允许优化该技术的应用。这些包括:左冠状动脉干病变的手术或血管内治疗的适应症的发展,支架置入技术的优化,评估伴随病理对左冠状动脉干病变患者治疗有效性的意义
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信